Indeed, dominant-interfering forms of AKT (PI3K) can prevent the activity of HRASV12 in the PTEN-AKT effector pathway, preventing progression of ectopic melanocytes to melanoma (Michailidou et al., 2009). Here, AKT1 is linked to melanoma.